On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.

At Pitt, the MiGEL Lab and its robot liquid handler play a major role in processing surveillance testing samples. Learn how samples are pooled, tested and sequenced to help in the battle against COVID-19.

In some patients with HIV who take medication, the virus still shows up in their blood. A study led by John Mellors has found “repliclones”—large clones of HIV-infected cells that produce infectious virus particles—are to blame.

A team of undergraduate students and faculty members is using techniques from engineering to provide a picture of how well students are complying with safety standards on the Pittsburgh campus.

A team led by Madhu Choudhary has joined a national trial testing therapies to keep COVID-19 patients out of the hospital. Funded through Operation Warp Speed, it is one of a handful of new trials at Pitt.

Hundreds of people in Western Pennsylvania will have the opportunity to participate in clinical research trials for vaccines against the coronavirus that causes COVID-19, UPMC and the University of Pittsburgh announced today.

The symptoms, treatment and other medical information about the novel coronavirus can be difficult for some people to understand. Six Pitt Med students led the production of an illustrated guide written in plain language to help.